Mutual Fund Details

DSP Healthcare Fund Direct - Growth

Name: DSP Healthcare Fund Direct - Growth
Brand: DSP Mutual Fund

Equity Pharma

NAV

₹44.3190

as on 17 Sep 2024, 09:00 PM

₹-0.0640(0.14%)

Last Change

Scheme Ratings

Pharma

5Y Returns

rated by Value Research

Pharma

Rankings based on 5Y Returns | as on 19 Sep 2024

DSP Healthcare Fund Direct - Growth

34.21%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

33.73%

Mirae Asset Healthcare Fund Direct - Growth

32.90%

SBI Healthcare Opportunities Fund Direct Plan-Growth

31.78%

Nippon India Pharma Fund Direct-Growth

31.16%

Schemes Managed By

Chirag Dagli

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,70,769

₹1,77,895

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹77,895

Profit (absolute return)

77.90%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

22.06%

In the last 6 months

28.62%

In the last 1 year

55.49%

In the last 3 years

77.90%

In the last 5 years

336.17%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

DSP Healthcare Fund Direct - Growth

as of 31 Aug 2024, 05:30 AM

₹2,934.17 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 1 month.

0.56%

Expense Ratio

Plan

Growth

5.63%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 1 month.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Aug 2024

Sort By

Value

Sector

Healthcare

91.81%

₹2,693.86 Cr

Insurance

1.76%

₹51.64 Cr

Others

6.43%

₹188.67 Cr

Sectors Holding in this Mutual Fund

as on 31 Aug 2024

Sort By

Value

Sector

Healthcare

91.81%

₹2,693.86 Cr

Insurance

1.76%

₹51.64 Cr

Others

6.43%

₹188.67 Cr

Companies Holding in this Mutual Fund

as on 31 Aug 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.50%

₹366.77 Cr

Suven Pharmaceuticals Ltd.

9.38%

₹275.23 Cr

Cipla Ltd.

8.28%

₹242.95 Cr

Ipca Laboratories Ltd.

7.31%

₹214.49 Cr

Lupin Ltd.

7.14%

₹209.50 Cr

Others

55.39%

₹1,625.24 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Aug 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.50%

₹366.77 Cr

Suven Pharmaceuticals Ltd.

9.38%

₹275.23 Cr

Cipla Ltd.

8.28%

₹242.95 Cr

Ipca Laboratories Ltd.

7.31%

₹214.49 Cr

Lupin Ltd.

7.14%

₹209.50 Cr

Others

55.39%

₹1,625.24 Cr

View All

Funds in this Category

This fund's returns:

21.15%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About DSP Healthcare Fund Direct - Growth

DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Chirag Dagli. It has an AUM of ₹2,934.17 Crores and the latest NAV decalared is ₹44.319 as on 19 Sep 2024 at 7:40 am.

DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 55.49%, in last 3 years is 77.90% and 340.81% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.